Practicing research ethics: Private-sector physicians & pharmaceutical clinical trials

被引:10
|
作者
Fisher, Jill A. [1 ]
机构
[1] Arizona State Univ, Women & Gender Studies, Tempe, AZ 85287 USA
关键词
USA; clinical trials; pharmaceutical industry; private sector; physician investigators; research ethics;
D O I
10.1016/j.socscimed.2008.02.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This paper focuses on constructions of research ethics by primary care physicians in the USA as they engage in contract research for the pharmaceutical industry. Drawing first on historical studies of physicians as investigators and then on 12 months of qualitative fieldwork in the Southwestern US, this paper analyzes the shifting, contextualized ethics that shape physicians' relationships with patients/subjects and pharmaceutical companies. Just as physicians followed professional codes of ethics prior to the codification of acceptable research conduct in the 1980s, physicians today continue to develop tacit systems of research ethics. This paper argues that private-sector physicians primarily conceptualize their ethical conduct in relation to the pharmaceutical companies hiring them, not to human subjects they enroll in clinical trials. This is not to say that these physicians do not follow the formal U.S. regulation to protect human subjects, but rather that their financial relationships with the pharmaceutical industry have a greater influence on their identities as researchers and on their constructions of their ethical responsibilities. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2495 / 2505
页数:11
相关论文
共 50 条
  • [31] Clinical research trials in private practice.
    Erlichman, MS
    Delauter, SK
    Hayes, PN
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1166 - 1166
  • [32] The Impact of the US Priority Review Voucher on Private-Sector Investment in Global Health Research and Development
    Robertson, Andrew S.
    Stefanakis, Rianna
    Joseph, Don
    Moree, Melinda
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (08):
  • [33] ETHICS IN CLINICAL DRUG TRIAL RESEARCH IN PRIVATE PRACTICE
    Beran, R. G.
    Beran, M. E.
    MEDICINE AND LAW, 2006, 25 (03): : 503 - 512
  • [34] Clinical research in private sector: Which strategic analysis?
    Ruffier, A.
    Pointreau, Y.
    Sacier, V.
    Balavoine, M.
    Lamrani-Ghaouti, A.
    Guihard, S.
    Rivera, S.
    CANCER RADIOTHERAPIE, 2023, 27 (6-7): : 469 - 473
  • [35] Truth in clinical research trials involving pharmaceutical sponsorship
    Commens, CA
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (12) : 648 - 649
  • [36] GLOBALIZATION OF THE PHARMACEUTICAL-INDUSTRY - OPPORTUNITIES FOR PHYSICIANS IN CLINICAL RESEARCH
    DZIEWANOWSKA, ZE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10): : 890 - 892
  • [37] The ethics of reporting and disseminating results of clinical research trials
    Bell, JG
    Brady, M
    Copeland, LJ
    CANCER, 2004, 100 (06) : 1107 - 1109
  • [38] Research sponsorship, financial relationships, and the process of research in pharmaceutical clinical trials
    Gardner, William
    Lidz, Charles W.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2006, 1 (02) : 11 - 18
  • [39] THE ETHICS OF CLINICAL TRIALS RESEARCH IN SEVERE MOOD DISORDERS
    Nugent, Allison C.
    Miller, Franklin G.
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    BIOETHICS, 2017, 31 (06) : 443 - 453
  • [40] The Ebola clinical trials: a precedent for research ethics in disasters
    Calain, Philippe
    JOURNAL OF MEDICAL ETHICS, 2018, 44 (01) : 3 - 8